Cavlek Tatjana Vilibic, Sternak Suncanica Ljubin, Kaic Bernard, Zarkovic Kamelija, Marina Branka Marusic Della, Sojat Ljerka Cvitanovic, Basnec Anica, Galinovic Gordana Mlinaric
Croatian National Institute of Public Health, Zagreb.
Acta Microbiol Immunol Hung. 2007 Mar;54(1):57-63. doi: 10.1556/AMicr.54.2007.1.6.
We studied five patients with SSPE during a 10-year period (1994-2004). The first clinical symptoms developed at the age of 5-11 years. All patients were vaccinated regularly against measles according to the official immunization schedule. One patient had measles at the age of 18 months. Two of them had a history of morbilliform rash (unrecognized measles) at the age of six and seven months, respectively. In two patients, with no history of measles before vaccination the disease started after varicella infection. Using complement-fixation (F) test and EIA, antibodies to measles virus (MV) were detected in the CSF and sera of all patients. The CF-antibody titers ranged from 1:1024 to 1:65536 in sera and from 1:16 to 1:128 in CSF samples. MV antigen was detected in brain imprints using IFA in two patients. Electron microscopic analysis revealed intranuclear viral inclusions (MV nucleocapsids). Using RT-PCR, viral RNA was found in both patients. Nucleotide sequence analysis showed that the viruses found in the brain tissue belonged to the wild-type MV D6 genotype [7].
我们在10年期间(1994 - 2004年)研究了5例亚急性硬化性全脑炎(SSPE)患者。最初的临床症状出现在5至11岁。所有患者均按照官方免疫计划定期接种麻疹疫苗。1例患者在18个月大时患过麻疹。其中2例分别在6个月和7个月大时有过麻疹样皮疹(未被识别的麻疹)病史。在2例接种疫苗前无麻疹病史的患者中,疾病在水痘感染后开始。使用补体结合(F)试验和酶免疫分析(EIA),在所有患者的脑脊液和血清中均检测到麻疹病毒(MV)抗体。血清中补体结合抗体滴度范围为1:1024至1:65536,脑脊液样本中为1:16至1:128。在2例患者中使用间接荧光抗体法(IFA)在脑印片中检测到MV抗原。电子显微镜分析显示核内病毒包涵体(MV核衣壳)。使用逆转录聚合酶链反应(RT-PCR),在这2例患者中均发现了病毒RNA。核苷酸序列分析表明,在脑组织中发现的病毒属于野生型MV D6基因型[7]。